Production (Stage)
Serina Therapeutics, Inc.
SER
$6.00
$0.254.35%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.95% | -360.70% | -19.52% | -146.29% | -1,005.61% |
| Total Depreciation and Amortization | -32.00% | 833.33% | 3.70% | 235.29% | 92.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.85% | -153.79% | -93.63% | -79.15% | 583.67% |
| Change in Net Operating Assets | -14.95% | 31.20% | 1,913.46% | -4,657.14% | 92.45% |
| Cash from Operations | -174.06% | -3,892.56% | -189.26% | -826.97% | -122.43% |
| Capital Expenditure | -- | 92.86% | 97.48% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 92.86% | 97.48% | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -76.24% |
| Total Debt Repaid | -- | 92.31% | 33.33% | -1,116.67% | -18.18% |
| Issuance of Common Stock | -75.00% | -- | 514.29% | 498,700.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,358.75% | -- | -- | -- | -- |
| Cash from Financing | 80.24% | 38,800.00% | 4,200.00% | 48,890.91% | -72.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.67% | 1,050.00% | -152.32% | -122.02% | -87.88% |